STOCK TITAN

Legend Biotech to Host 2022 R&D Day on Monday, October 3, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Legend Biotech Corporation (NASDAQ: LEGN) will host its in-person and virtual Research & Development Day on October 3, 2022, at 10:00 a.m. ET in New York City. The event aims to provide a comprehensive overview of the company's platforms and pipeline developments from its senior leadership team, including CEO Ying Huang and other key executives. A live webcast will be accessible, with a replay available within 24 hours post-event. Investors can register here.

Positive
  • None.
Negative
  • None.

SOMERSET, N.J.--(BUSINESS WIRE)-- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced it will host its in-person and virtual Research & Development Day on Monday, October 3, 2022 at 10:00 a.m. ET at Andaz 5th Avenue in New York City. Please click here to register for the event.

The event will feature a comprehensive overview of our platforms and the latest developments in our pipeline through presentations from members of Legend’s senior leadership team:

  • Ying Huang, Ph.D., Chief Executive Officer
  • Guowei Fang, Ph.D., Senior Vice President, Global Head of Research and Early Development
  • Lida Pacaud, M.D., Vice President, Clinical Development
  • Steve Gavel, Vice President, Commercial Development, US & Europe

A live webcast and presentation will be available to investors and other interested parties on the Legend Biotech website under “Events and Presentations”. A replay of the webcast can be viewed as early as 24 hours after the event.

About Legend Biotech

Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of cutting-edge therapeutics for patients worldwide.

Learn more at www.legendbiotech.com and follow us on Twitter and LinkedIn.

Source: Legend Biotech

Investors:

Joanne Choi, Senior Manager, Investor Relations, Legend Biotech

joanne.choi@legendbiotech.com

Crystal Chen, Manager, Investor Relations, Legend Biotech

crystal.chen@legendbiotech.com

Press:

Tina Carter, Corporate Communications Lead, Legend Biotech

tina.carter@legendbiotech.com

(908) 331-5025

Source: Legend Biotech Legend Biotech Corporation

FAQ

What date is the Research & Development Day for Legend Biotech?

Legend Biotech's Research & Development Day is scheduled for October 3, 2022.

What time will the Research & Development Day start for LEGN?

The event will start at 10:00 a.m. ET.

Where is the Research & Development Day for Legend Biotech being held?

The event will take place in New York City.

Will there be a webcast for Legend Biotech's Research & Development Day?

Yes, there will be a live webcast available for investors.

How can I register for the Legend Biotech Research & Development Day?

You can register for the event here.

When will the replay of the Legend Biotech event be available?

A replay of the webcast will be available 24 hours after the event.

Legend Biotech Corporation American Depositary Shares

NASDAQ:LEGN

LEGN Rankings

LEGN Latest News

LEGN Stock Data

6.00B
181.05M
1.31%
51.22%
12.49%
Biotechnology
Healthcare
Link
United States of America
Somerset